Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03409614 |
|---|---|
| Brief Title: | Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer |
| First Submitted : | January 10, 2018 |
| First Submitted that Met QC Criteria : | January 23, 2018 |
| First Posted : | January 24, 2018 |
| Last Update Submitted that Met QC Criteria : | April 24, 2024 |
| Last Update Posted : | April 25, 2024 |